ReviewThe Biochemical journal2025
The more we learn, the more diverse it gets: structures, functions and evolution in the Phosphofructokinase Superfamily.
Review in The Biochemical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Article
- Engineering of glycerol-derived aldolase pathway improves D-allulose synthesis in a glucose-glycerol dual-carbon system.Archives of microbiology · 2026Article
- Stepwise assembly of virulence-associated traits in the intracellular pathogenbioRxiv : the preprint server for biology · 2026Article
- Functional conservation with mechanistic drift: AMP activation in the evolution of archaeal sugar kinases.Molecular biology and evolution · 2026Article
- Mechanistic and applied study of phosphofructokinases, the "gatekeeper" of the glycolytic pathway on the central carbon metabolism.Metabolic engineering communications · 2026Article
- Targeting phosphofructokinase in cancer: integrating natural products for metabolic reprogramming and therapeutic innovation.Frontiers in pharmacology · 2026Review
- Multiscale Simulation of Phosphofructokinase-1 Assemblies: Capturing the Interplay between Specific and Transient Interactions.The journal of physical chemistry. B · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The enzyme 6-phosphofructokinase (PFK) phosphorylates d-fructose 6-phosphate, producing d-fructose 1,6-bisphosphate. The canonical version-discovered almost 90 years ago-is ATP-dependent, allosterically regulated and catalyses the first committed step in glycolysis. However, beyond this textbook enzyme, there is fascinating functional and structural variety among PFKs across the tree of life. While PFKs are found in two non-homologous superfamilies, here, we review the universally distributed enzymes in one, the Phosphofructokinase Superfamily. We focus on summarising the diversity within this superfamily. A key partition regards the identity of the phosphate donor, which can be ATP or inorganic pyrophosphate (PPi). Considerable insights into functional and evolutionary aspects of the ATP- and PPi-dependent PFKs have come through structural biology, with 45 structures now available in the Protein Data Bank. One recent highlight was the use of cryoEM and molecular dynamics simulations to illuminate the structural basis of allosteric regulation in human liver PFK. Others were to explore interactions of drug-like small molecules with the PFKs from Trypanosoma brucei and human liver, revealing new routes to antibiotics and immune modulators, respectively. In contrast with the ATP-dependent enzymes, PPi-dependent PFKs are typically non-allosteric and catalyse a readily reversible reaction. Some also play an additional physiological role by phosphorylating d-sedoheptulose 7-phosphate. We discuss why these properties are plausibly ancestral. Finally, we also emphasise how much remains to be discovered. For example, the 45 experimentally determined structures are from only 14 species. Nine decades in, it is still a great time to be studying PFK.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.